Report Feature
The future of the global platelet rich plasma market looks promising with opportunities in orthopedics, cosmetic surgery and dermatology, ophthalmic surgery, neurosurgery, and general surgery applications. The global platelet rich plasma market is expected to grow with a CAGR of 12%-14% from 2020 to 2025. The major drivers for this market are increasing demand for plasma therapy in therapeutic areas, rising geriatric population, and growing sports surgeries.
A total of XX figures / charts and XX tables are provided in this more than 150 pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global platelet rich plasma market report, please download the report brochure.
In this market, pure PRP is the largest product type of platelet rich plasma, whereas orthopedics is the largest application. Growth in various segments of the platelet rich plasma market are given below:
The study includes trends and forecast for the global platelet rich plasma market by product, origin, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
- Pure PRP
- Leukocyte-Rich PRP
- Leukocyte-Rich Fibrin PRP
By Origin [Value ($ Million) shipment analysis for 2014 – 2025]:
- Autologous PRP
- Allogeneic PRP
- Homologous PRP
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
- Orthopedics
- Cosmetic Surgery and Dermatology
- Ophthalmic Surgery
- Neurosurgery
- General Surgery
- Others
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
- Hospitals
- Orthopedic Clinics
- Dermatology Clinics
- Others
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Germany
- France
-
Asia Pacific
- China
- India
- Japan
-
The Rest of the World
- Brazil
Some of the platelet rich plasma companies profiled in this report includes Arthrex, Terumo BCT, EmCyte, DePuy Synthes, Zimmer Biomet, Stryker, Glofinn, DR. PRP America, Harvest Technologies, and Adistem.
Lucintel forecasts that pure PRP will remain the largest product segment over the forecast period, as it provides effective results in bone regeneration and is less inflammatory as compared to other products.
Within this market, orthopedics will remain the largest segment by application over the forecast period due to increasing aging population and rising incidence of road accidents.
North America will remain the largest region over the forecast period due to increasing application areas of platelet rich plasma in therapeutics, rising cases of orthopedic disorders, and presence of major players of PRP in the region.
|
Features of the Global Platelet Rich Plasma Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global platelet rich plasma market by product (pure PRP, leukocyte-rich PRP, and leukocyte-rich fibrin PRP), origin (autologous PRP, allogeneic PRP, and homologous PRP), application (orthopedics, cosmetic surgery & dermatology, ophthalmic surgery, neurosurgery, general surgery, and others), end user (hospitals, orthopedic clinics, dermatology clinics, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global platelet rich plasma market? Q.5 What are the business risks and threats to the global platelet rich plasma market? Q.6 What are the emerging trends in this platelet rich plasma market and the reasons behind them? Q.7 What are some changing demands of customers in this platelet rich plasma market? Q.8 What are the new developments in this platelet rich plasma market? Which companies are leading these developments? Q.9 Who are the major players in this platelet rich plasma market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this platelet rich plasma market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global platelet rich plasma market? |
Report Scope
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Product (Pure PRP, Leukocyte-Rich PRP, and Leukocyte-Rich Fibrin PRP), Origin (Autologous PRP, Allogeneic PRP, and Homologous PRP), Application (Orthopedics, Cosmetic Surgery & Dermatology, Ophthalmic Surgery, Neurosurgery, General Surgery, and Others), and End User (Hospitals, Orthopedic Clinics, Dermatology Clinics, and Others) |
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
1. Executive Summary
7.2 Emerging Trends in the Global Platelet Rich Plasma Market
4.1 Global Platelet Rich Plasma Market by Region
4.2.1 Market by Product: Pure PRP, Leukocyte-Rich PRP, and Leukocyte-Rich Fibrin PRP
4.2.2 Market by Origin: Autologous PRP, Allogeneic PRP, and Homologous PRP
4.2.3 Market by Application: Orthopedics, Cosmetic Surgery and Dermatology, Ophthalmic Surgery, Neurosurgery, General Surgery, and Others
4.2.4 Market by End User: Hospitals, Orthopedic Clinics, Dermatology Clinics, and Others
4.2.5 The United States Platelet Rich Plasma Market
4.2.6 The Canadian Platelet Rich Plasma Market
4.2.7 The Mexican Platelet Rich Plasma Market
4.3.1 Market by Product: Pure PRP, Leukocyte-Rich PRP, and Leukocyte-Rich Fibrin PRP
4.3.2 Market by Autologous PRP, Allogeneic PRP, and Homologous PRP
4.3.3 Market by Application: Orthopedics, Cosmetic Surgery and Dermatology, Ophthalmic Surgery, Neurosurgery, General Surgery, and Others
4.3.3 Market by End User: Hospitals, Orthopedic Clinics, Dermatology Clinics, and Others
4.3.4 The Platelet Rich Plasma Market of United Kingdom
4.3.5 The Spanish Platelet Rich Plasma Market
4.3.6 The German Platelet Rich Plasma Market
4.3.7 The French Platelet Rich Plasma Market
4.4.1 Market by Product: Pure PRP, Leukocyte-Rich PRP, and Leukocyte-Rich Fibrin PRP
4.4.2 Market by Autologous PRP, Allogeneic PRP, and Homologous PRP
4.4.3 Market by Application: Orthopedics, Cosmetic Surgery and Dermatology, Ophthalmic Surgery, Neurosurgery, General Surgery, and Others
4.4.4 Market by End User: Hospitals, Orthopedic Clinics, Dermatology Clinics, and Others
4.4.5 The Chinese Platelet Rich Plasma Market
4.4.6 The Indian Platelet Rich Plasma Market
4.4.7 The Japanese Platelet Rich Plasma Market
4.5.1 Market by Product: Pure PRP, Leukocyte-Rich PRP, and Leukocyte-Rich Fibrin PRP
4.5.2 Market by Autologous PRP, Allogeneic PRP, and Homologous PRP
4.5.3 Market by Application: Orthopedics, Cosmetic Surgery and Dermatology, Ophthalmic Surgery, Neurosurgery, General Surgery, and Others
4.5.4 Market by End User: Hospitals, Orthopedic Clinics, Dermatology Clinics, and Others
4.5.5 Brazilian Platelet Rich Plasma Market
7.1.1 Growth Opportunities for the Global Platelet Rich Plasma Market by Product
7.1.2 Growth Opportunities for the Global Platelet Rich Plasma Market by Origin
7.1.3 Growth Opportunities for the Global Platelet Rich Plasma Market by Application
7.1.4 Growth Opportunities for the Global Platelet Rich Plasma Market by End User
7.1.5 Growth Opportunities for the Global Platelet Rich Plasma Market by Region
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
